Sun Pharma Current Affairs, GK & News

Lupin Ltd launched its version of Favipiravir under brand name Covihalt, in India

The Indian Pharmaceuticals major company, Lupin, has launched its version of the antiviral drug Favipiravir to treat the deadly COVI 19 disease. It has been informed by the company in an exchange filing. The drug has been launched with the brand name ‘Covihalt’ for the treatment of mild-to-moderate COVID 19 among the patients. The Drug ..

Month: 

Category: 

Topics: 

Sun Pharma signs deal with ICGEB to develop India’s first dengue vaccine

India’s largest pharmaceutical company Sun Pharma has signed deal with International Centre for Genetic Engineering and Biotechnology (ICGEB) for clinical development Cissampelos pariera (Cipa), India’s first vaccine (drug) for the treatment of dengue. The partnership between Sun Pharma and ICGEB aims to develop` safe, effective and affordable botanical drug Cipa. Key Facts Under the deal, ..

Month: 

Topics: